Talib W, Abed I, Raad D, Alomari R, Jamal A, Jabbar R
Foods. 2024; 13(17).
PMID: 39272454
PMC: 11395675.
DOI: 10.3390/foods13172687.
Gao W, Zhou J, Morshedi M
Cancer Cell Int. 2024; 24(1):163.
PMID: 38725047
PMC: 11084024.
DOI: 10.1186/s12935-024-03338-w.
Bakhshandeh B, Ranjbar N, Abbasi A, Amiri E, Abedi A, Mehrabi M
Bioeng Transl Med. 2023; 8(2):e10383.
PMID: 36925674
PMC: 10013802.
DOI: 10.1002/btm2.10383.
Lu Z, Liu Y, Yan J, Zhang Y, Gong L, Liu B
Int J Mol Sci. 2022; 23(21).
PMID: 36361695
PMC: 9654127.
DOI: 10.3390/ijms232112903.
Sheikh E, Tran T, Vranic S, Levy A, Bonfil R
Bosn J Basic Med Sci. 2022; 22(5):683-698.
PMID: 35490363
PMC: 9519160.
DOI: 10.17305/bjbms.2021.7399.
A DNA Aptamer That Inhibits the Aberrant Signaling of Fibroblast Growth Factor Receptor in Cancer Cells.
Eguchi A, Ueki A, Hoshiyama J, Kuwata K, Chikaoka Y, Kawamura T
JACS Au. 2021; 1(5):578-585.
PMID: 34467321
PMC: 8395645.
DOI: 10.1021/jacsau.0c00121.
Genome-Wide Characterization, Evolution, and Expression Analysis of the Leucine-Rich Repeat Receptor-Like Protein Kinase (LRR-RLK) Gene Family in .
Meng J, Yang J, Peng M, Liu X, He H
Life (Basel). 2020; 10(9).
PMID: 32899802
PMC: 7555646.
DOI: 10.3390/life10090176.
Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling.
Paul M, Grubb H, Hristova K
J Biol Chem. 2020; 295(29):9917-9933.
PMID: 32467228
PMC: 7380177.
DOI: 10.1074/jbc.RA120.013639.
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
Shi X, Kaller M, Rokavec M, Kirchner T, Horst D, Hermeking H
Cell Mol Gastroenterol Hepatol. 2020; 10(2):391-418.
PMID: 32304779
PMC: 7423584.
DOI: 10.1016/j.jcmgh.2020.04.002.
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities.
Khan M, Nasti T, Buchwald Z, Weichselbaum R, Kron S
Cancer J. 2019; 25(2):106-115.
PMID: 30896532
PMC: 6518392.
DOI: 10.1097/PPO.0000000000000369.
The RTK Interactome: Overview and Perspective on RTK Heterointeractions.
Paul M, Hristova K
Chem Rev. 2018; 119(9):5881-5921.
PMID: 30589534
PMC: 6918702.
DOI: 10.1021/acs.chemrev.8b00467.
MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
Zhang J, Zhang J, Qiu W, Zhang J, Li Y, Kong E
J Neurooncol. 2018; 139(3):547-562.
PMID: 29774498
PMC: 6132976.
DOI: 10.1007/s11060-018-2903-8.
The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse.
Azoulay-Alfaguter I, Strazza M, Peled M, Novak H, Muller J, Dustin M
Sci Signal. 2017; 10(491).
PMID: 28790195
PMC: 9437928.
DOI: 10.1126/scisignal.aal2880.
Defects in the adult abdominal integument ofDrosophila caused by mutations intorpedo, a DER homolog.
Madhavan K, Madhavan M
Rouxs Arch Dev Biol. 2017; 204(5):330-335.
PMID: 28306127
DOI: 10.1007/BF02179501.
Effects of FGFR2 kinase activation loop dynamics on catalytic activity.
Karp J, Sparks S, Cowburn D
PLoS Comput Biol. 2017; 13(2):e1005360.
PMID: 28151998
PMC: 5313233.
DOI: 10.1371/journal.pcbi.1005360.
Drosophila Protein Kinase CK2: Genetics, Regulatory Complexity and Emerging Roles during Development.
Bandyopadhyay M, Arbet S, Bishop C, Bidwai A
Pharmaceuticals (Basel). 2016; 10(1).
PMID: 28036067
PMC: 5374408.
DOI: 10.3390/ph10010004.
Clinical Evaluation of Insulin like Growth Factor-I and Vascular Endothelial Growth Factor with Alloplastic Bone Graft Material in the Management of Human Two Wall Intra-Osseous Defects.
Devi R, Dixit J
J Clin Diagn Res. 2016; 10(9):ZC41-ZC46.
PMID: 27790578
PMC: 5072078.
DOI: 10.7860/JCDR/2016/21333.8476.
No irradiation required: The future of humanized immune system modeling in murine hosts.
McIntosh B, Brown M
Chimerism. 2016; 6(1-2):40-5.
PMID: 27171577
PMC: 5063082.
DOI: 10.1080/19381956.2016.1162360.
Ligand-dependent responses of the silkworm prothoracicotropic hormone receptor, Torso, are maintained by unusual intermolecular disulfide bridges in the transmembrane region.
Konogami T, Yang Y, Ogihara M, Hikiba J, Kataoka H, Saito K
Sci Rep. 2016; 6:22437.
PMID: 26928300
PMC: 4772477.
DOI: 10.1038/srep22437.
Gastric cancer and the epoch of immunotherapy approaches.
Niccolai E, Taddei A, Prisco D, Amedei A
World J Gastroenterol. 2015; 21(19):5778-93.
PMID: 26019442
PMC: 4438012.
DOI: 10.3748/wjg.v21.i19.5778.
